Rein Therapeutics, Inc. (RNTX) Corporate Subsidiaries
Rein Therapeutics, Inc. (RNTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RNTX
CIK: 1420565
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerNatalie Verbanac
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-04 | 2026-09-04 | 8-K | 0001193125-26-383726 | View SEC Doc Filr Page |
| 8-K | 2026-08-27 | 2026-08-21 | 8-K | 0001193125-26-371260 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097425 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097114 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-350270 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000935836-26-000391 | View SEC Doc Filr Page |
| 8-K | 2026-07-21 | 2026-07-20 | 8-K | 0001193125-26-310315 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-14 | — | SCHEDULE 13G/A Filing | 0002060757-26-000043 | View SEC Doc Filr Page |
| ARS | 2026-06-08 | 2025-12-31 | ARS | 0001193125-26-260814 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-08 | — | DEFA14A | 0001193125-26-260812 | View SEC Doc Filr Page |
| DEF 14A | 2026-06-08 | 2026-07-20 | DEF 14A | 0001193125-26-260809 | View SEC Doc Filr Page |
| 4 | 2026-05-28 | 2026-05-21 | 4 | 0001193125-26-245832 | View SEC Doc Filr Page |
| PRE 14A | 2026-05-28 | 2026-07-20 | PRE 14A | 0001193125-26-245389 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001193125-26-225352 | View SEC Doc Filr Page |
| 4 | 2026-05-13 | 2026-04-30 | 4 | 0001193125-26-220718 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-08 | — | SCHEDULE 13G/A Filing | 0001697316-26-000012 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-08 | — | SCHEDULE 13G Filing | 0001104659-26-057607 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-07 | — | SCHEDULE 13G Filing | 0002073679-26-000049 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-06 | — | SCHEDULE 13G Filing | 0000935836-26-000227 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-04-30 | 8-K | 0001193125-26-204006 | View SEC Doc Filr Page |
| 424B5 | 2026-05-04 | — | 424B5 | 0001193125-26-202429 | View SEC Doc Filr Page |
| EFFECT | 2026-04-30 | — | EFFECT Filing | 9999999995-26-001417 | View SEC Doc Filr Page |
| CORRESP | 2026-04-28 | — | CORRESP Filing | 0001193125-26-187839 | View SEC Doc Filr Page |
| CORRESP | 2026-04-28 | — | CORRESP Filing | 0001193125-26-187838 | View SEC Doc Filr Page |
| S-1 | 2026-04-28 | — | S-1 | 0001193125-26-187803 | View SEC Doc Filr Page |